Actrapid has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and type 2 diabetes, when the body is unable to use insulin effectively (one study involving 182 patients).
Al controlar los niveles de glucosa en sangre, disminuyen los síntomas y las complicaciones de la diabetes.